Simon May is the Senior Vice President and President of the Diagnostics and Genomics Group at Agilent Technologies Inc., a leading global company focused on life sciences, diagnostics, and applied chemical markets. With a robust background in the life sciences industry, May has been instrumental in driving innovation and growth within Agilent's Diagnostics and Genomics Group. His leadership has been pivotal in expanding the company's portfolio of cutting-edge solutions that cater to the evolving needs of the genomics and diagnostics markets. Before joining Agilent Technologies, Simon May held various leadership positions at other prominent organizations in the life sciences sector. His career is marked by a consistent track record of spearheading successful initiatives that have led to significant advancements in genomics and diagnostics technologies. At Agilent, May oversees strategic planning, product development, and market expansion efforts for the Diagnostics and Genomics Group. Under his guidance, the group has achieved notable milestones, including the launch of innovative products that have strengthened Agilent's position as a leader in the industry. May's role at Agilent Technologies involves not only managing the day-to-day operations of the Diagnostics and Genomics Group but also fostering collaborations with key stakeholders, including research institutions and healthcare providers. His vision for the group is to continue pushing the boundaries of what is possible in genomics and diagnostics, ultimately contributing to improved patient outcomes and scientific discoveries. Simon May's dedication to excellence and his strategic approach to leadership make him a vital asset to Agilent Technologies and the broader life sciences community.